4.5 Review

Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells

Journal

STEM CELLS INTERNATIONAL
Volume 2018, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2018/4516454

Keywords

-

Funding

  1. Fondo de Investigaciones Sanitarias (FIS) of Instituto Carlos III (ISCIII) [PI14/02079, PI17/02242]
  2. European Regional Development Fund (FEDER)
  3. EuroNanoMed II (Catalonia, Spain) [AC15/00092]
  4. Fundacio Marato TV3 (Catalonia, Spain) [337/C/2013]
  5. Portuguese Science and Technology Foundation (FCT) [SFRH/BD/76270/2011]
  6. La Asociacion Espanola Contra el Cancer (AECC)
  7. Plan Estrategico de Investigacion e Innovacion en Salud (PERIS)
  8. Fundação para a Ciência e a Tecnologia [SFRH/BD/76270/2011] Funding Source: FCT

Ask authors/readers for more resources

There are remarkable similarities in the description of cancer stem cells (CSCs) and cancer cells with mesenchymal phenotype. Both cell types are highly tumorigenic, resistant against common anticancer treatment, and thought to cause metastatic growth. Moreover, cancer cells are able to switch between CSC and non-CSC phenotypes and vice versa, to ensure the necessary balance within the tumor. Likewise, cancer cells can switch between epithelial and mesenchymal phenotypes via well-described transition (EMT/MET) that is thought to be crucial for tumor propagation. In this review, we discuss whether, and to which extend, the CSCs and mesenchymal cancer cells are overlapping phenomena in terms of mechanisms, origin, and implication for cancer treatment. As well, we describe the dynamism of both phenotypes and involvement of the tumor microenvironment in CSC reversion and in EMT.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available